Olumiant Patient and HCP Website
Brand: Olumiant (baricitinib), Tablets
Parent Company: Eli Lilly
Drug Type: Prescription
Drug Category: Rheumatology
Campaign: Launch, Post-Launch
Targeting: HCPs, Patients, Caregivers
Patient Website: https://www.olumiant.com/
HCP Website: https://www.olumiant.com/hcp/